查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1980752

2026-2034年全球植入式心臟节律管理设备市场规模、份额、趋势和成长分析报告

Global Implantable Cardiac Rhythm Management Devices Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计植入式心臟节律管理设备的市场规模将从 2025 年的 201.1 亿美元增长到 2034 年的 485.9 亿美元，2026 年至 2034 年的复合年增长率为 10.3%。

由于心血管疾病和心律不整的盛行率不断上升，全球植入式心臟节律管理装置（ICR）市场正经历显着成长。 ICR，包括心律调节器和植入式心臟整流去颤器（ICD），广泛用于监测和调节异常心律。这些装置在预防危及生命的心臟事件和提高患者存活率方面发挥着至关重要的作用。

人们对心臟健康的日益关注以及心臟植入式设备技术的进步是推动市场扩张的主要因素。现代植入式设备体积更小、效率更高，并且能够透过无线连接进行远端监测。这些创新使医疗专业人员能够持续监测患者的心臟活动，并据此调整治疗方案。此外，全球人口老化也显着促进了心臟节律管理解决方案的需求成长。

展望未来，由于技术的持续创新和医疗保健投资的不断增加，市场预计将保持持续成长。各公司正致力于开发电池续航力更长、监控功能更强大的新一代植入式设备。随着医疗保健系统将心臟疾病的早期发现和管理置于优先地位，植入式心臟节律监测设备将在改善心血管护理方面继续发挥关键作用。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

  • 市场谱系展望
  • 渗透率和成长前景分析
  • 价值链分析
  • 法律规范
    • 标准与合规性
    • 监管影响分析
  • 市场动态
    • 市场驱动因素
    • 市场限制因素
    • 市场机会
    • 市场挑战
  • 波特五力分析
  • PESTLE分析

第四章 全球植入式心臟节律管理设备市场：依装置类型划分

  • 市场分析、洞察与预测
  • 心臟再同步治疗装置
  • 植入式心臟整流去颤器
  • 起搏器

第五章 全球植入式心臟节律管理设备市场：依技术划分

  • 市场分析、洞察与预测
  • 双心室
  • 双腔体
  • 单室

第六章 全球植入式心臟节律管理设备市场：依组件划分

  • 市场分析、洞察与预测
  • 带领
  • 脉衝发生器

第七章 全球植入式心臟节律管理设备市场：依最终用户划分

  • 市场分析、洞察与预测
  • 门诊手术中心
  • 心臟病诊所
  • 医院

第八章：全球植入式心臟节律管理设备市场：依年龄组别划分

  • 市场分析、洞察与预测
  • 成人
  • 儿童

第九章 全球植入式心臟节律管理设备市场：依地区划分

  • 区域分析
  • 北美市场分析、洞察与预测
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲市场分析、洞察与预测
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太市场分析、洞察与预测
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 东南亚
    • 其他亚太国家
  • 拉丁美洲市场分析、洞察与预测
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲国家
  • 中东和非洲市场分析、洞察与预测
    • 沙乌地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中东和非洲国家

第十章 竞争格局

  • 最新趋势
  • 公司分类
  • 供应链和销售管道合作伙伴（根据现有资讯）
  • 市场占有率和市场定位分析（基于现有资讯）
  • 供应商情况（基于现有资讯）
  • 策略规划

第十一章：公司简介

  • 主要公司的市占率分析
  • 公司简介
    • Medtronic Plc
    • Abbott Laboratories
    • Boston Scientific Corporation
    • Biotronik SE & Co. KG
    • MicroPort Scientific Corporation
    • LivaNova PLC
    • Koninklijke Philips NV
    • Lepu Medical Technology（Beijing）Co. Ltd
    • Johnson & Johnson（Biosense Webster/Formerly St. Jude Medical）
    • Stryker Corporation
简介目录
Product Code: VMR112115231

The Implantable Cardiac Rhythm Management Devices Market size is expected to reach USD 48.59 Billion in 2034 from USD 20.11 Billion (2025) growing at a CAGR of 10.3% during 2026-2034.

The Global Implantable Cardiac Rhythm Management Devices Market is witnessing strong growth due to the increasing prevalence of cardiovascular diseases and cardiac arrhythmias. Implantable cardiac rhythm management devices, including pacemakers and implantable cardioverter defibrillators (ICDs), are widely used to monitor and regulate abnormal heart rhythms. These devices play a critical role in preventing life-threatening cardiac events and improving patient survival rates.

Growing awareness about heart health and advancements in cardiac device technology are major drivers of market expansion. Modern implantable devices are becoming smaller, more efficient, and capable of remote monitoring through wireless connectivity. These innovations enable healthcare providers to continuously monitor patient heart activity and adjust treatment plans accordingly. Additionally, the aging global population is significantly contributing to the increasing demand for cardiac rhythm management solutions.

Looking ahead, the market is expected to experience sustained growth due to continuous technological innovation and rising healthcare investments. Companies are focusing on developing next-generation implantable devices with longer battery life and enhanced monitoring capabilities. As healthcare systems prioritize early detection and management of cardiac conditions, implantable cardiac rhythm management devices will continue to play a vital role in improving cardiovascular care.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Device Type

  • Cardiac Resynchronization Therapy Device
  • Implantable Cardioverter Defibrillator
  • Pacemaker

By Technology

  • Biventricular
  • Dual Chamber
  • Single Chamber

By Component

  • Leads
  • Pulse Generator

By End User

  • Ambulatory Surgical Centers
  • Cardiac Specialty Clinics
  • Hospitals

By Age Group

  • Adult
  • Pediatric

COMPANIES PROFILED

  • Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Biotronik SE Co KG, MicroPort Scientific Corporation, LivaNova PLC, Koninklijke Philips NV, Lepu Medical Technology Beijing Co Ltd, Johnson Johnson Biosense Webster formerly St Jude Medical, Stryker Corporation
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: BY DEVICE TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Device Type
  • 4.2. Cardiac Resynchronization Therapy Device Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Implantable Cardioverter Defibrillator Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Pacemaker Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Technology
  • 5.2. Biventricular Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Dual Chamber Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Single Chamber Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: BY COMPONENT 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Component
  • 6.2. Leads Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Pulse Generator Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: BY END USER 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast End User
  • 7.2. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Cardiac Specialty Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: BY AGE GROUP 2022-2034 (USD MN)

  • 8.1. Market Analysis, Insights and Forecast Age Group
  • 8.2. Adult Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.3. Pediatric Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: BY REGION 2022-2034(USD MN)

  • 9.1. Regional Outlook
  • 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.2.1 By Device Type
    • 9.2.2 By Technology
    • 9.2.3 By Component
    • 9.2.4 By End User
    • 9.2.5 By Age Group
    • 9.2.6 United States
    • 9.2.7 Canada
    • 9.2.8 Mexico
  • 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.3.1 By Device Type
    • 9.3.2 By Technology
    • 9.3.3 By Component
    • 9.3.4 By End User
    • 9.3.5 By Age Group
    • 9.3.6 United Kingdom
    • 9.3.7 France
    • 9.3.8 Germany
    • 9.3.9 Italy
    • 9.3.10 Russia
    • 9.3.11 Rest Of Europe
  • 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.4.1 By Device Type
    • 9.4.2 By Technology
    • 9.4.3 By Component
    • 9.4.4 By End User
    • 9.4.5 By Age Group
    • 9.4.6 India
    • 9.4.7 Japan
    • 9.4.8 South Korea
    • 9.4.9 Australia
    • 9.4.10 South East Asia
    • 9.4.11 Rest Of Asia Pacific
  • 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.5.1 By Device Type
    • 9.5.2 By Technology
    • 9.5.3 By Component
    • 9.5.4 By End User
    • 9.5.5 By Age Group
    • 9.5.6 Brazil
    • 9.5.7 Argentina
    • 9.5.8 Peru
    • 9.5.9 Chile
    • 9.5.10 South East Asia
    • 9.5.11 Rest of Latin America
  • 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.6.1 By Device Type
    • 9.6.2 By Technology
    • 9.6.3 By Component
    • 9.6.4 By End User
    • 9.6.5 By Age Group
    • 9.6.6 Saudi Arabia
    • 9.6.7 UAE
    • 9.6.8 Israel
    • 9.6.9 South Africa
    • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

  • 10.1. Recent Developments
  • 10.2. Company Categorization
  • 10.3. Supply Chain & Channel Partners (based on availability)
  • 10.4. Market Share & Positioning Analysis (based on availability)
  • 10.5. Vendor Landscape (based on availability)
  • 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Company Profiles
    • 11.2.1 Medtronic Plc
    • 11.2.2 Abbott Laboratories
    • 11.2.3 Boston Scientific Corporation
    • 11.2.4 Biotronik SE & Co. KG
    • 11.2.5 MicroPort Scientific Corporation
    • 11.2.6 LivaNova PLC
    • 11.2.7 Koninklijke Philips N.V
    • 11.2.8 Lepu Medical Technology (Beijing) Co. Ltd
    • 11.2.9 Johnson & Johnson (Biosense Webster / Formerly St. Jude Medical)
    • 11.2.10 Stryker Corporation